ClinicalTrials.Veeva

Menu

Prospective Functional Outcome Study of the Knee (PFOSK)

Tufts University logo

Tufts University

Status

Terminated

Conditions

Osteoarthritis of the Knee

Treatments

Device: Total Knee Arthroplasty

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT02079493
11109-Conformis

Details and patient eligibility

About

The purpose of this study is to obtain patient-oriented and clinically-oriented physical function outcomes both pre-operatively and post-operatively in patients receiving a total knee arthroplasty .

Full description

This study aims to use up to 75 patients at 3 centers to determine a baseline short-term postoperative physical function status of patients undergoing a total knee arthroplasty through patient and clinically based assessments. The KOOS score will collect data on the patient's physical function, stiffness, and pain. The BERG balance, TUG, and TUDS tests will be used quantitatively to assess the patient's ability to conduct activities of daily living like walking for an extended period of time, standing from a seated position, and maintaining balance while performing a series of actions.

Enrollment

40 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient is a male or non-pregnant female age 18 years or older at time of study
  • Patient is a candidate for a total knee arthroplasty
  • Patient is willing and able to comply with postoperative scheduled clinical and radiographic evaluations and rehabilitation.

Exclusion criteria

  • Patients younger than 18 years of age
  • Patients with a primary diagnosis other than osteoarthritis of the knee as determined by an orthopaedic surgeon
  • Patients who have had any previous lower extremity procedure
  • Patients with a BMI greater than or equal to 40
  • Patients with an active infection within the affected knee joint Patients with a neuromuscular or neurosensory deficiency that may limit the ability of the patient to evaluate the safety and efficacy of the device
  • Patient is diagnosed with systemic disease or metabolic disorder leading to progressive bone deterioration (e.g. Lupus Erythematosus, Paget's Disease)
  • Patient is immunologically suppressed or receiving chronic steroids in excess of normal physiological requirements (e.g. greater than 30 days)
  • Patient has a known sensitivity to device materials
  • Non-English speaking patients
  • Patient is a prisoner

Trial design

40 participants in 1 patient group

Total Knee Arthroplasty patients
Description:
TKA patients
Treatment:
Device: Total Knee Arthroplasty

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems